Ouro Medicines
South San Francisco, US · Founded 2024 · 20 employees on LinkedIn · 3 known investors
Ouro Medicines is a biotechnology company developing cell-depleting therapies aimed at resetting the immune system to treat chronic immune-mediated diseases such as autoimmune and autoinflammatory conditions. It is advancing a pipeline of biologics and small molecules across immunology and related therapeutic areas.
Founders & leadership
J
JaideepFounding Chief Executive Officer
NM
Neely MozaffarianChief Medical Officer
C
ChristinaGeneral Counsel & Chief Operating Officer
Investors · 3
Founder mafia
2 people who came through Ouro Medicines went on to found or lead other companies.
Frequently asked questions
- What does Ouro Medicines do?
- Ouro Medicines is a biotechnology company developing cell-depleting therapies aimed at resetting the immune system to treat chronic immune-mediated diseases such as autoimmune and autoinflammatory conditions. It is advancing a pipeline of biologics and small molecules across immunology and related therapeutic areas.
- Who are Ouro Medicines's investors?
- Ouro Medicines's investors include Monograph Capital Partners, New Enterprise Associates (NEA), Norwest Venture Partners.
- Where is Ouro Medicines headquartered?
- Ouro Medicines is headquartered in South San Francisco, US.